Skip to content

Research into the Development and Clinical Translation of a Wearable System for Targeted Regulation of the Rapid Eye Movement (REM) Stage in Adolescents with Psychological Trauma

Research into the Development and Clinical Translation of a Wearable System for Targeted Regulation of the Rapid Eye Movement (REM) Stage in Adolescents with Psychological Trauma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126952
Enrollment
Unknown
Registered
2026-06-21
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental disorders associated with psychological trauma

Interventions

Experimental group:Eye Movement Desensitization and Reprocessing (EMDR) combined with targeted memory reactivation (TMR) during rapid eye movement sleep period.
Control group:EMDR + REM-phase pseudo-stimulation

Sponsors

Beijing Huilongguan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for patients group: (1) Patients diagnosed with post-traumatic stress disorder, depressive disorder, anxiety disorder, bipolar disorder or other mental disorders according to ICD-10; (2) Aged 12–18 years; (3) A positive screening result on the CTQ scale, i.e. a score of =13 on the emotional abuse subscale, or >=10 on the physical abuse subscale, or =8 on the sexual abuse subscale, or =15 on the emotional neglect subscale, or >= 10 on the physical neglect subscale; (4) The patient agrees to participate in this study and has signed an informed consent form. 2. Inclusion criteria for healthy control group: (1) did not meet the diagnostic criteria for any psychiatric disorder according to ICD-10; (2) were matched to the patient group for age and educational level; (3) were aged 12–18 years; (4) agreed to participate in the study and provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for patients group: (1) Patients with schizophrenia, alcohol use disorder or substance use disorder; (2) Use of benzodiazepines or other sleep-inducing medication during the period from one week prior to the start of the study until the end of the study period; (3) Consumption of alcohol or coffee during the study period; (4) Presence of suicidal or self-harming thoughts; (5) History of neurological disorders or recent history of severe head trauma with loss of consciousness; (6) Irregular sleep-wake patterns (e.g., night shifts, jet lag) and sleepwalking; (7) Participation in, or current participation in, other non-pharmacological treatments such as repetitive transcranial magnetic stimulation, non-convulsive electroconvulsive therapy or cognitive behavioural therapy within the past three months. 2. Exclusion criteria for the healthy control group: (1) Organic brain disease; (2) Severe systemic disorders; (3) Psychiatric illness or seizure risk; (4) History of suicidality or self-harm; (5) Substance dependence; (6) Circadian rhythm disruption or sleepwalking; (7) Presence of metal implants, electronic devices, or any other contraindications to magnetic resonance imaging (MRI).

Design outcomes

Primary

MeasureTime frame
Objective sleep structure parameters;Symptoms of trauma;

Secondary

MeasureTime frame
The strength of functional connectivity within and between key brain networks;Subjective sleep measures;Spectral characteristics of resting-state electroencephalograms;EEG parameters during task performance;skin conductance response;Sleep Diary;PSG's objective indicators;Resting-state and task-based EEG;Brain connectivity;

Countries

China

Contacts

Public ContactLi Xiaohong

Beijing Huilongguan Hospital, Capital Medical University

lxhshy2002@163.com+86 158 1040 2944

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026